| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-14 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-12 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-11 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
7e-09 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.24 |
4e-06 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.2 |
8e-05 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.19 |
0.0003 |